The primary role of the Mouse Genetics Core Facility (MGCF) is to facilitate the use of mouse moleculargenetics at MSKCC for in vivo studies of gene functions germane to cancer. Relevant fields where mousemodels can be applied include cell growth and behavior, cellular differentiation, embryonic development,immunobiology, genome integrity, and malignant transformation. The Core consists of 3 groups: theTransgenic Mouse Group, the Colony Management Group, and the ES Cell Culture Group. Together theyprovide the following services: (1) Production of transgenic mice: transgene DNA purification, pronuclearinjection, genotyping of founder mice, and breeding of positive founders to provide G1 progeny. (2) GeneTargeting: electroporation of gene targeting vector into ES cells, selection and identification of clones, andcryopreservation of targeted ES cell clones. (3) Production of gene targeted mice: generation of chimericmice by blastocyst injection and identification of germline chimeras. (4) Long term storage of transgenic,gene targeted, congenic, and other mutant mouse strains by cryopreservation of sperm or embryos. (5)Rederivation by embryo transfer or IVF for strain importation and recovery. (6) Performance of specializedanimal surgical procedures and embryological techniques. (7) Provision of specialized mouse strains/linesfor investigators' research. (8) Provision of husbandry service to assist investigators in the maintenance oftransgenic, gene targeted, and mutant strains of mice. (9) Comprehensive management of transgenic, genetargeted, and mutant mouse colonies for investigators. (10) Genotyping of transgenic, gene targeted, andmutant mouse lines for users. (11) Assistance in all aspects of ES cell culture and ES cell establishmentfrom transgenic, gene targeted, and mutant mice. (12) Consultation & training in mouse genomemanipulation and mouse genetics.In the past several years, the promotion of translational research at the Center and the rapid advancement ofgenomic technologies, had led to a dramatic increase in the number of laboratories using mouse models intheir research. To meet these demands, the Core has implemented four new services, hired additionalpersonnel, and re-organized the staff so that transgenic and gene targeted mice can be efficiently produced.Furthermore, the Core now offers more comprehensive services to aid investigators not just in creating theanimal models of interest but also in maintaining, cross-breeding, and utilization of the lines as experimentalmodels.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA008748-43
Application #
7671809
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-07-31
Project End
2012-12-31
Budget Start
2008-07-31
Budget End
2008-12-31
Support Year
43
Fiscal Year
2008
Total Cost
$506,878
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Sauter, Craig S; Matasar, Matthew J; Schoder, Heiko et al. (2018) A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL. Blood 131:1805-1808
Berry, Sean L; Tierney, Kevin P; Elguindi, Sharif et al. (2018) Five years' experience with a customized electronic checklist for radiation therapy planning quality assurance in a multicampus institution. Pract Radiat Oncol 8:279-286
Breitbart, William (2018) Jimmie C. Holland, M.D. Psychosomatics 59:123-124
Geller, Shamir; Pitter, Ken; Moskowitz, Alison et al. (2018) Treatment of Vulvar Mycosis Fungoides Tumors With Localized Radiotherapy. Clin Lymphoma Myeloma Leuk 18:e279-e281
Romesser, Paul B; Pei, Xin; Shi, Weiji et al. (2018) Prostate-Specific Antigen (PSA) Bounce After Dose-Escalated External Beam Radiation Therapy Is an Independent Predictor of PSA Recurrence, Metastasis, and Survival in Prostate Adenocarcinoma Patients. Int J Radiat Oncol Biol Phys 100:59-67
Ankerst, Donna P; Straubinger, Johanna; Selig, Katharina et al. (2018) A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts. Eur Urol 74:197-203
Scott, Jessica M; Nilsen, Tormod S; Gupta, Dipti et al. (2018) Exercise Therapy and Cardiovascular Toxicity in Cancer. Circulation 137:1176-1191
Routy, Bertrand; Le Chatelier, Emmanuelle; Derosa, Lisa et al. (2018) Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359:91-97
Hou, Xiaowei; Burstein, Shana R; Long, Stephen Barstow (2018) Structures reveal opening of the store-operated calcium channel Orai. Elife 7:
Mori, Shoko; Navarrete-Dechent, Cristian; Petukhova, Tatyana A et al. (2018) Tumor Board Conferences for Multidisciplinary Skin Cancer Management: A Survey of US Cancer Centers. J Natl Compr Canc Netw 16:1209-1215

Showing the most recent 10 out of 8799 publications